491 Validated Asian Prognosis Tool Accurately Predicts Gastric Cancer Outcome of Ethnically Diverse Patient Population at an American National Comprehensive Cancer Center

2016 ◽  
Vol 150 (4) ◽  
pp. S1184
Author(s):  
Bryan S. Goldner ◽  
Kijun Song ◽  
Taeil Son ◽  
Jong Won Kim ◽  
Laleh Melstrom ◽  
...  
2017 ◽  
Vol 35 (8_suppl) ◽  
pp. 143-143
Author(s):  
Lauren M. Hamel ◽  
Louis Penner ◽  
Elisabeth I. Heath ◽  
Dina Lansey ◽  
Michael Anthony Carducci ◽  
...  

143 Background: Few patients, especially racial/ethnic minorities, enroll in clinical trials (CT), in part due to patient-oncologist communication. Question prompt lists (QPLs) improve communication, but have not been tested in CT discussions in a diverse patient population. We describe the development and acceptability of a theory-based QPL to improve communication and enrollment of White and Black men in prostate cancer CTs. Methods: Two existing QPLs were adapted by a team of communication scientists, psychologists, clinicians and patients. Guiding theories were the common ingroup identity model, which suggests people from different social groups can better achieve goals when they are on the same team, and patient-centered communication, which suggests that patient active participation improves clinical communication. The revised QPL included text to encourage patients to see themselves and their oncologist as a team, and 33 questions about CTs to encourage patients to participate actively in clinical interactions that include a CT discussion. To test acceptability, we recruited 15 Black or White men currently enrolled in a prostate cancer CT at an urban comprehensive cancer center. We asked patients to provide feedback on the QPL, to endorse which questions were most important, and for suggested improvements. Results: Patients participated anonymously. All patients said the QPL would be useful. Four patients reported liking the graphics/layout. Six patients reported liking the team text, but one commented that it was unnecessary. Three patients liked that the QPL included many questions, several of which they had not thought to ask when they discussed a CT with their oncologist. Ten patients endorsed the questions they thought were important to ask (M = 24 questions, SD = 9). The most frequently endorsed questions were what is already known about this treatment and how serious are the side effects? Conclusions: Patients found the QPL to be acceptable and useful. The QPL was revised according to patient feedback. We are testing the revised QPL's influence on patient-oncologist communication about CTs, patient understanding of CTs offered, and patient decisions to enroll in a CT.


2011 ◽  
Vol 121 (S5) ◽  
pp. S314-S314
Author(s):  
Jeffrey Cheng ◽  
Nancy Jiang ◽  
Benjamin Malkin

2012 ◽  
Vol 8 (1) ◽  
pp. e1-e7 ◽  
Author(s):  
Michael A. Kallen ◽  
James A. Terrell ◽  
Paula Lewis-Patterson ◽  
Jessica P. Hwang

Excessive appointment delay time has been identified as a primary source of overall patient appointment dissatisfaction among the general medical patient population as well as oncology patients.


2012 ◽  
Vol 30 (4_suppl) ◽  
pp. 63-63 ◽  
Author(s):  
Takeru Wakatsuki ◽  
Pierre Oliver Bohanes ◽  
Wu Zhang ◽  
Armin Gerger ◽  
Dongyun Yang ◽  
...  

63 Background: Previous study suggests that high basal Lemur Tyrosine Kinase 3 (LMTK3) expression was associated with advanced stage of primary breast cancers as well as decreased overall and disease-free survival. LMTK3 was also found overexpressed in gastric cancer. Our previous data showed the mutant variants of two single nucleotide polymorphisms (SNPs) in LMTK3 (rs8108419 and rs9989661) were independently associated with reduced time to tumor recurrence (TTR) in colon cancer (CC). We hypothesized that LMTK3 rs808419 and rs9989661 may predict TTR in a cohort of localized gastric cancer patients. Methods: Either blood or FFPE tissue specimens obtained from 137 localized (stage Ib-IV) GA patients (54 females and 83 males) were included in this study. All patients were treated with surgery alone or surgery and adjuvant (radio)-chemotherapy at the University of Southern California/Norris Comprehensive Cancer Center (USC/NCCC), the Los Angeles County/University of Southern California Medical Center, or the Memorial Sloan-Kettering Cancer Center from 1992 to 2008. The median follow-up was 3.3 years. LMTK3 rs8108419 and rs9989661 were determined by PCR-RFLP. The primary endpoint of the study was TTR. Results: LMTK3 rs9989661 was significantly associated with TTR in females GA patients. Female patients with minor C allele (TC or CC) (n=25) of LMTK3 rs9989661 showed significantly longer median TTR=7.0 (95%CI: 2.1-8.3+) years compared to those harboring homozygous TT genotype. (n=28), TTR=1.7 (95%CI: 0.7-7.0+) years.( log-rank p=0.025; univariate analysis). After Cox proportional hazards model adjustment for stage and type of adjuvant chemotherapy, this result remained significant (HR: 0.14, 95%CI: 0.02-0.94, multivariate Wald p value = 0.043 in the dominant model). No significant association was found between TTR and LMTK3 rs9989661 in men and rs8108419 in both genders. Conclusions: This pilot study demonstrating LMTK3 rs9989661 may be potential molecular marker to predict TTR in female localized GA. Larger prospective trials are warranted to confirm these findings, and in vitro and in vivo studies are needed to identify the underlying biological mechanism.


Sign in / Sign up

Export Citation Format

Share Document